Pharma News, 2015

THURSDAY, Oct.

An experimental drug originally identified in a National Cancer Institute library of chemical compounds as a potential therapy for brain and basal cell cancers improves the symptoms of mice with a for...

A new drug has been found superior to current treatments in slowing the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had kept it in check, accordi...

Sanofi announced that the U.

Scientists at the University School of Medicine in St.

Aspirin may double the chances of survival for patients with gastrointestinal cancers, according to the results of a new study recently presented at the 2015 European Cancer Congress in Vienna, Austri...

Abbott will increase its investment in research and development and expand its manufacturing plants in India to cater to domestic market and exports, the healthcare company announced today.

The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved Merck's Marizev (omarigliptin) 25 mg and 12.

The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Teva Pharmaceutical Industries' once-daily COPAXONE (  injection) 20mg injection for the prevention of rel...

Zafgen has secured orphan drug designation from the European Commission (EC) for beloranib inhibitor to treat craniopharyngioma, a rare form of benign brain tumor.

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given marketing authorization for Amgen's two new treatment options for patient...

Recently, FDA published the final rule implementing section 708 of the Food and Drug Administration Safety and Innovation Act (FDASIA).